Study of an investigational drug for diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes for at least 1 year, or you are a healthy volunteer.
- Your blood sugar control (HbA1c) must be within a certain range (6.5% to 9.5% for type 2 diabetes, 6% to 8.5% for type 1 diabetes).
- You use a long-acting insulin (like Lantus) daily for type 2 diabetes (in one part of the study).
- You have not had a serious low blood sugar episode or needed emergency care for high blood sugar in the last 6 months.
- You do not have any major heart, stomach, or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new injectable medication (IN-B00009) to see if it helps lower blood sugar in people with type 2 diabetes who are not currently on diabetes medicine. It might be an option if diet and exercise alone are not enough to control your diabetes.
This study tests the safety of a new medicine called NNC1679-0001 in healthy adults and those with type 2 diabetes. The goal is to see if it is safe before larger trials.
This study tests an investigational drug called LY3938577 in healthy people and people with type 1 diabetes. It looks at how the drug affects the body and whether it might help control blood sugar.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.